The Influence of Non-E. Coli or Extended-Spectrum β-Lactamase-Producing Bacterial Growth on the Follow-Up Procedure of Infants with the First Febrile Urinary Tract Infection.


Journal

Indian journal of pediatrics
ISSN: 0973-7693
Titre abrégé: Indian J Pediatr
Pays: India
ID NLM: 0417442

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 27 05 2021
accepted: 27 01 2022
medline: 19 6 2023
pubmed: 22 6 2022
entrez: 21 6 2022
Statut: ppublish

Résumé

To evaluate the effects of non-E. coli or extended-spectrum β-lactamase-positive (ESBL-positive) microorganism growth in the first febrile urinary tract infection (UTI) of infants on laboratory findings or renal parenchymal damage presenting the severity of inflammation, anatomic abnormalities defined by imaging studies, and recurrent UTIs in the follow-up period. The data of patients aged between 2 and 24 mo and followed up for at least 6 mo with febrile UTI guideline of the authors' pediatric-nephrology clinic, were retrospectively analyzed. Ultrasonography was performed in all the cases at the time of UTI and dimercaptosuccinic-acid (DMSA) at least 4 mo after the infection. Voiding cystourethrography (VCUG) was performed only if ultrasonography findings were abnormal, the uptake deformity was detected in DMSA scan, or the patients experienced recurrent UTIs. The patients were grouped concerning E. coli or non-E. coli and ESBL-PB or non-ESBL-BP growth in the urine cultures. There were 277 infants followed up for 28.55 ± 15.24 (6-86) mo. The causative microorganisms were non-E. coli in 73 (26.4%) and ESBL-PB in 58 (20.9%) cases. CRP values, pyuria, and leukocyte-esterase positivity were significantly higher in UTIs caused by E. coli compared to non-E. coli bacteria. All clinical and laboratory findings were similar between the ESBL-PB and non-ESBL groups, but abnormal ultrasonography findings were more common in non-E. coli group. E. coli causes more severe inflammation, but non-E. coli infections are more frequently associated with ultrasound abnormalities. However, ESBL production did not affect either laboratory or radiological findings in the present cohort.

Identifiants

pubmed: 35727527
doi: 10.1007/s12098-022-04183-3
pii: 10.1007/s12098-022-04183-3
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

677-682

Informations de copyright

© 2022. The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation.

Références

Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med. 2003;348:195–202.
doi: 10.1056/NEJMoa021698 pubmed: 12529459
Shaw KN, Gorelick M, McGowan KL, Yakscoe NM, Schwartz JS. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics. 1998;102:e16.
Baumer JH, Jones RW. Urinary tract infection in children, National Institute for Health and Clinical Excellence. Arch Dis Child Educ Pract Ed. 2007;92:189–92. 
Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–610.
Buettcher M, Trueck J, Niederer-Loher A, et al. Swiss consensus recommendations on urinary tract infections in children. Eur J Pediatr. 2021;180:663–74.
doi: 10.1007/s00431-020-03714-4 pubmed: 32621135
Amin O, Prestel C, Gonzalez MD, et al. Urinary tract infections with extended-spectrum-β-lactamase-producing bacteria: case-control study. Pediatr Infect Dis J. 2020;39:211–6.
doi: 10.1097/INF.0000000000002531 pubmed: 32032306
Topaloglu R, Er I, Dogan BG, et al. Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr Nephrol. 2010;25:919–25.
doi: 10.1007/s00467-009-1431-3 pubmed: 20151161
Hernández Marco R, Guillén Olmos E, Bretón-Martínez JR, et al. Community-acquired febrile urinary tract infection caused by extended-spectrum bet-lactamase-producing bacteria in hospitalised infants. Enferm Infecc Microbiol Clin. 2017;35:287–92.
doi: 10.1016/j.eimc.2016.01.012 pubmed: 26976379
Flokas ME, Karanika S, Alevizakos M, Mylonakis E. Prevalence of ESBL-producing enterobacteriaceae in pediatric bloodstream infections: a systematic review and meta-analysis. PLoS One. 2017;12:e0171216.
Kim YH, Yang EM, Kim CJ. Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants. J Pediatr (Rio J). 2017;93:260–6.
doi: 10.1016/j.jped.2016.06.009 pubmed: 27842212
Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol. 1985;15:105–9.
Shaikh N, Borrell JL, Evron J, Leeflang MM. Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children. Cochrane Database Syst Rev. 2015;1:CD009185. Update in: Cochrane Database Syst Rev. 2020;9:CD009185.
Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J Pediatr. 2013;163:1417–21.
doi: 10.1016/j.jpeds.2013.06.078 pubmed: 23919903
Ristola MT, Löyttyniemi E, Hurme T. Factors associated with abnormal imaging and infection recurrence after a first febrile urinary tract infection in children. Eur J Pediatr Surg. 2017;27:142–9.
pubmed: 26855368
Shaikh N, Wald ER, Keren R, et al. Predictors of non-escherichia coli urinary tract infection. Pediatr Infect Dis J. 2016;35:1266–8.
doi: 10.1097/INF.0000000000001301 pubmed: 27434831 pmcid: 5071137
Preda I, Jodal U, Sixt R, Stokland E, Hansson S. Imaging strategy for infants with urinary tract infection: a new algorithm. J Urol. 2011;185:1046–52.
doi: 10.1016/j.juro.2010.10.043 pubmed: 21247606
Marcus N, Ashkenazi S, Yaari A, Samra Z, Livni G. Non-escherichia coli versus escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and outcome. Pediatr Infect Dis J. 2005;24:581–5.
doi: 10.1097/01.inf.0000168743.57286.13 pubmed: 15998996
Grover SA, Komaroff AL, Weisberg M, Cook EF, Goldman L. The characteristics and hospital course of patients admitted for presumed acute pyelonephritis. J Gen Intern Med. 1987;2:5–10.
doi: 10.1007/BF02596242 pubmed: 3543268
Albaramki JH, Abdelghani T, Dalaeen A, et al. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: risk factors and antibiotic resistance. Pediatr Int. 2019;61:1127–32.
doi: 10.1111/ped.13911 pubmed: 31206219
Dotis J, Printza N, Marneri A, Gidaris D, Papachristou F. Urinary tract infections caused by extended–spectrum beta lactamase–producing bacteria in children: a matched case control study. Turk J Pediatr. 2013;55:571–4.
pubmed: 24577973
Park SY, Kim JH. Clinical Significance of extended-spectrum β-lactamase-producing bacteria in first pediatric febrile urinary tract infections and differences between age groups. Child Kidney Dis. 2017;21:128–35.
doi: 10.3339/jkspn.2017.21.2.128
Kizilca O, Siraneci R, Yilmaz A, et al. Risk factors for community–acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr Int. 2012;54:858–62.
doi: 10.1111/j.1442-200X.2012.03709.x pubmed: 22882781
Han SB, Lee SC, Lee SY, Jeong DC, Kang JH. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae. BMC Infect Dis. 2015;15:414.
doi: 10.1186/s12879-015-1153-z pubmed: 26464143 pmcid: 4604622
Ditchfield MR, Summerville D, Grimwood K, et al. Time course of transient cortical scintigraphic defects associated with acute pyelonephritis. Pediatr Radiol. 2002;32:849–52.
doi: 10.1007/s00247-002-0784-6 pubmed: 12447588
Jakobsson B, Svensson L. Transient pyelonephritic changes on 99mTechnetium-dimercaptosuccinic acid scan for at least five months after infection. Acta Paediatr. 1997;86:803–7.
doi: 10.1111/j.1651-2227.1997.tb08601.x pubmed: 9307157
Agras K, Ortapamuk H, Naldöken S, Tuncel A, Atan A. Resolution of cortical lesions on serial renal scans in children with acute pyelonephritis. Pediatr Radiol. 2007;37:153–8.
doi: 10.1007/s00247-006-0362-4 pubmed: 17171352

Auteurs

Mustafa Kavruk (M)

Department of Pediatrics, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, Turkey.

Eren Soyaltın (E)

Department of Pediatrics, Division of Nephrology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, 35320, Turkey.

Gökçen Erfidan (G)

Department of Pediatrics, Division of Nephrology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, 35320, Turkey.

Seçil Arslansoyu Çamlar (S)

Department of Pediatrics, Division of Nephrology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, 35320, Turkey. secilars@yahoo.com.

Demet Alaygut (D)

Department of Pediatrics, Division of Nephrology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, 35320, Turkey.

Fatma Mutlubaş (F)

Department of Pediatrics, Division of Nephrology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, 35320, Turkey.

Nisel Yılmaz (N)

Department of Clinical Microbiology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, Turkey.

Belde Kasap Demir (B)

Department of Pediatrics, Division of Nephrology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, İzmir, 35320, Turkey.
Department of Pediatrics, Division of Nephrology and Rheumatology, Izmir Katip Çelebi University Medical Faculty, İzmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH